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Abstract 
The prevalence of obesity has been increasing across the globe at an unprecedented rate, and 
obesity is associated with a number of diseases, including diabetes, hypertension, and certain 
types of cancer. In recent years, increasing evidence has shown that obesity can also cause 
cognitive impairment, and research is increasingly aimed at elucidating both the nature of, and 
the mechanisms behind, these impairments in the brain. Because the hippocampus has been 
shown to be particularly vulnerable to these effects, both of the studies presented in this thesis 
aimed to investigate the effects of high-fat diet-induced obesity on hippocampal synaptic 
plasticity. In study 1, female rats were placed on either a high-fat diet (HFD; 45% saturated fat) 
or a control diet (CD; 10% fat) for 16 weeks, after which a subset of females were sacrificed, 
with the remainder being bred to investigate the transgenerational effects of HFD exposure.  
Body weights, food weights, and oral glucose tolerance were measured throughout the feeding 
period. All offspring were weaned onto a CD, and were sacrificed at PND 56. In both the 
maternal and offspring generations, various organ weights were collected at sacrifice, and long-
term potentiation (LTP) was measured in the CA1 dendritic field of acutely prepared 
hippocampal slices. Results showed impaired blood glucose tolerance as early as one month on 
the HFD in the maternal generation, as well as significantly heavier retroperitoneal fat pads, 
with no differences in body weight. LTP was also significantly impaired in HFD animals in the 
maternal generation. HFD offspring were trending towards increased body weight, with no 
differences in retroperitoneal fat pad weight or oral glucose tolerance. There were also no diet-
induced differences in LTP in the offspring. Study 2 had a similar design, although the animals 
began feeding in adolescence (PND 28), as opposed to young adulthood (PND 56, as in study 1), 
to investigate the effects of critical periods of exposure. The feeding period was also shortened 
to 10 weeks, and the CD was changed so as to eliminate its refined sugar content. Finally, 
because of the longitudinal nature of the transgenerational portion of study 2, the timing was 
such that only data from the maternal generation is presented here. In study 2, the HFD group 
was significantly heavier after only one week on the diet, and had increased adiposity at 
sacrifice. Differences in oral glucose tolerance, however, were not apparent until after 2 months 
on the diet, and there were no diet-induced differences in LTP. This lack of significant 
electrophysiological findings is consistent with the lack of differences seen by another student in 
the Morris Water Maze, and suggests that the shortened feeding period in study 2 may not have 
allowed sufficient time for the HFD to impair synaptic function.  
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1.0 Overview 
Obesity is a health condition wherein there is an accumulation of body fat to 
the point of negative health outcomes. In Western societies, the increasing 
abundance of food and, specifically, the availability of low quality foods as well as 
the rise of sedentary lifestyles, are ravaging the health of populations. Today, 
roughly one quarter of the Canadian population is obese (National Center for Health 
Statistics, 2011), which is an especially staggering proportion when the physical, 
social, and economic costs of the condition are considered. In fact, a recent estimate 
of the economic burden of obesity on the Canadian economy reported a total of $4.3 
billion in annual expenditures as a result of direct and indirect costs associated with 
obesity. Unfortunately, even this colossal figure is thought to be an underestimate, 
as it takes into account only a limited scope of the sequelae associated with 
overweight and obesity (Public Health Agency of Canada, 2012).  
As is well known, the growing prevalence of obesity is by no means restricted 
to Canada, and countries across the developed and developing world have as much 
as one third of their populations classified as obese (National Center for Health 
Statistics, 2011). What is particularly alarming is that, with the globalization of 
Western diets (diets high in refined sugars and saturated fats), obesity is becoming 
an epidemic, reaching even underdeveloped nations where populations are still 
struggling with poverty and malnutrition. In some areas, finding malnutrition 
coexisting with obesity, even in the same household, is not uncommon (WHO, 2013). 
According to the World Health Organisation, obesity has doubled worldwide since 
1980, and in 2008, 35% of adults aged 20 and over were overweight, while 11% 
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were obese; this amounts to over 1.4 billion overweight, and 500 million obese 
adults. However, perhaps the most shocking statistic from this report is that, 
globally, over 40 million children under the age of 5 were considered overweight in 
2011 (WHO, 2013).  
Of course, genetic factors do play a role in the development of obesity, and a 
proportion of individuals will indeed be more susceptible to the effects of a 
sedentary lifestyle and overeating than others; this cannot, however, explain the 
extreme and rapid worldwide increase in obesity. The cause of the current obesity 
epidemic is principally a problem of energy regulation imbalance: the 
overconsumption of calories without a parallel increase in energy expenditure 
(Kanoski and Davidson, 2011). In addition, obesity may lead to alterations in 
neurohormonal signalling pathways that ultimately result in the disruption of 
feeding regulation and the overconsumption of food, leading to a vicious cycle of 
cognitive disruption and energy overconsumption (Kanoski and Davidson, 2011).   
2.0 Obesity and its Associated Disorders 
Obesity is generally measured by Body Mass Index (BMI), which is calculated 
as body weight divided by the square of an individual’s height. Health risks increase 
with increasing BMI, and an individual with a BMI ≥30 kg/m2 is considered obese. 
The condition is associated with a multitude of negative health outcomes, including, 
but not limited to, Type II diabetes, cardiovascular disease, osteoarthritis, and 
certain forms of cancer (Balisteri et al, 2010). Obesity is also a principal component 
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of the metabolic syndrome, which includes dyslipidemia, hyperglycemia, insulin 
resistance, and hypertension (Vickers, 2011).  
Although most individuals seem to be at least vaguely familiar with the 
cardiovascular and other physiological effects of surplus weight, the effects of 
obesity on the central nervous system (CNS) remain largely ignored by the general 
population. Indeed, obesity has been associated with two types of CNS disturbance, 
the first being disrupted regulation of signalling pathways involved in appetite and 
energy homeostasis, and the second being cognitive disruption. The current study 
will focus on the second set of phenomena, namely the cognitive deficits observed 
with obesity, and, more specifically, on hippocampal functioning, which has been 
shown to be particularly susceptible to the effects of obesity.  
Epidemiological studies show that obese individuals, as well as those who 
consume diets high in saturated fats, experience an increased risk of dementia in old 
age (Kanoski and Davidson, 2011), as well as disruptions in cognitive performance 
throughout the lifespan (Elias et al, 2003). The observed deficits are particularly 
concerning given the ageing of our population and the concomitant increase in the 
incidence of Alzheimer’s disease and related dementias (Kanoski and Davidson, 
2011).  If obesity does indeed cause, or exacerbate age-related neurodegenerative 
disease, then we are only seeing the beginning of the social and economic 
repercussions of the current obesity epidemic (Balisteri et al, 2010).  
Evidence from human populations has led to the development of animal 
models of obesity in an attempt to better elucidate its effects on a range of 
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physiological systems. Here I will focus on those studies that relate to the disruption 
of brain function, as well as the mechanisms behind these effects. These efforts are 
in hope of both better understanding the condition, the global state of which seems 
to be rapidly worsening before our eyes, as well as developing potential 
interventions that might attenuate the effects of obesity on the brain.  
2.1 Obesity-related deficits: evidence from animal models 
Whereas the majority of animal research traditionally focused on the general 
metabolic effects of obesity, increasingly more work is being done with regards to 
its effects on cognition. Particularly, the hippocampus, a bilateral brain structure 
located in the medial temporal lobe (please see section 4.0), has become an area of 
focus, in large part because of its role in certain forms of learning and memory.  
2.1.1 Cognitive Deficits 
A number of studies in rodent models have examined the effects of different 
components of a Western diet on performance in a variety of behavioral tasks. 
Impairments in relational learning flexibility (Boitard et al, 2012), spatial reference 
and working memory (Kanoski and Davidson, 2010), contextual fear conditioning 
(Hwang et al, 2010), spontaneous alternation (McNay et al., 2010), and conditioned 
place preference (Privitera et al, 2011), have all been observed following various 
lengths of high-fat feeding, or else feeding of a diet high in both fat and refined 
carbohydrates. However, results are not consistent across studies; for example, 
Mielke et al (2006) showed no difference on Morris water maze (MWM) 
performance (a test of hippocampal-dependent spatial memory) in mice that had 
5 
 
been maintained on a high-fat diet (HFD) for 10 months, although a possible 
explanation for this is that the animals in both groups were relatively old when 
tested, perhaps leading to a floor effect. Comparison between studies, however, is 
complicated by heterogeneity of experimental protocols (e.g., rodent species, strain, 
age, length of feeding, constituents of experimental and control diets). There does, 
however, seem to be compelling evidence pointing to impairment of different 
aspects of hippocampal-dependent function, most notably spatial learning 
(Greenwood and Winocur, 1990; Greenwood and Winocur, 2001; Kanoski and 
Davidson, 2010; Kanoski and Davidson, 2011; Murray et al., 2009). The mechanisms 
behind the hippocampal disruption are not entirely clear, although impaired 
glucoregulation and insulin signalling, increases in neuroinflammation and lipid 
peroxidation, as well as disruptions in neurotrophins leading to decreased 
neurogenesis and synaptic plasticity, have all been proposed as potential culprits.  
2.1.2 Insulin 
The primary, and most well-recognized, role of insulin is that of 
glucoregulation, through the stimulation of glucose uptake into cells of the liver, 
skeletal muscle, and adipose tissue. The presence of insulin also inhibits proteolysis 
and lipolysis in muscle and adipose tissue, as well as gluconeogenesis in the liver. 
Insulin resistance is a characteristic of the metabolic syndrome, and is exceedingly 
common in obese individuals. Indeed, approximately 80% of obese individuals 
suffer from insulin resistance, leading to perpetually increased levels of insulin in 
the bloodstream (Martyn et al., 2008).  
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Peripheral insulin resistance has recently been suggested as a mediator of 
the cognitive deficits observed in individuals with the metabolic syndrome, and, 
more specifically, of hippocampal-related memory impairment. For example, in a 
study by Greenwood et al. (2003), poor glycemic control was associated with 
impaired delayed, but not immediate, verbal memory, with post-prandial elevations 
in blood glucose levels acutely exacerbating the impairment in adults with type 2 
diabetes. As well, in a study of individuals with early stage type 2 diabetes (less than 
10 years after initial diagnosis) Gold et al. (2007) reported deficits in hippocampal-
based memory performance with no seeming effect on other cognitive domains. The 
study also showed reduced hippocampal volumes in diabetic individuals, the 
magnitude of which was inversely correlated with glycemic control. Importantly, 
BMI, hypertension, and dyslipidemia did not contribute independently to the 
variance in hippocampal volume, suggesting that the reduction in hippocampal 
volume was due in large part to impaired glucoregulation resulting from insulin 
resistance.  
Evidence in animal models also points to a role of insulin resistance in 
cognitive impairment. Mielke et al (2005) showed that nutritionally-induced insulin 
resistance in hamsters significantly affected the neural insulin signalling pathway, 
as well as hippocampal synaptic plasticity, and Pathan et al (2008) showed that 
administration of rosiglitazone (an insulin sensitizer) attenuated the impairments in 
performance of the MWM in high fat diet-fed rats, so that their performance was 
similar to control rats fed a standard diet. Together, these studies show that there 
are indeed alterations in insulin signalling in the hippocampus of diet-induced 
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insulin-resistant animals, that these alterations resulted in an attenuation of insulin-
induced synaptic plasticity, and that insulin sensitization improves performance on 
hippocampal-dependent memory tasks.   
2.1.3 Leptin 
Along with insulin resistance, a large proportion of obese individuals are also 
resistant to the hormone leptin (Walker, 2008). Leptin is secreted primarily from 
white adipose tissue, and blood leptin levels vary proportionately with levels of 
white adipose tissue in the body. Leptin is able to cross the blood-brain barrier, and 
its primary role is in the regulation of appetite via its effects on the hypothalamus 
(Harvey et al, 2006). Two types of leptin-associated genetic mutations give rise to 
rodent models of obesity and type 2 diabetes: those in the hormone (ob/ob), and 
those in its receptor (db/db).  
Recently, a role for leptin outside of its role in hypothalamic energy 
regulation has been acknowledged. Indeed, leptin receptors are expressed in areas 
of the brain that are not normally associated with energy balance, including the 
hippocampus, thalamus, brain stem, and cerebellum (Harvey et al, 2006). It has 
been posited that leptin may modulate neuronal excitability and synaptic function, 
and leptin arising from peripheral tissues is thought to modulate hippocampal 
function in particular (Harvey et al, 2006). For example, intraperitoneal injection of 
leptin has been shown to influence hippocampal glucocorticoid expression (Harvey 
et al, 2006), and fluctuations in glucocorticoids have been shown to influence 
synaptic plasticity (Boitard et al, 2012).  Leptin also seems to influence NMDA 
8 
 
receptor expression and functioning, and the NMDA receptor is known to play an 
important role in hippocampal synaptic plasticity (Harvey et al., 2006; Walker et al, 
2008). 
2.1.4 Neurogenesis 
Although it was once thought that new neurons did not arise in the adult 
brain, a select few brain regions do indeed continue the process of neurogenesis, 
including the dentate gyrus of the hippocampus. Hippocampal neurogenesis 
participates in hippocampal-dependent memory, particularly flexible memory 
expression (Boitard et al, 2012). Memory flexibility that relies on a relational 
representation of previously acquired separate experiences is mediated by the 
hippocampus in mice, and, interestingly, represents a model of human declarative 
memory, which is particularly affected in overweight and obese adults (Nilsson and 
Nilsson, 2009). This point is of particular interest given the fact that HFD-fed mice 
have been shown to be impaired in memory flexibility, and have also been shown to 
have decreased hippocampal neurogenesis, as indicated by a decrease of immature 
neurons in the dentate gyrus (Boitard et al, 2012), suggesting a causal mechanism. 
Theories have been put forward regarding the mechanistic link between HFD 
consumption and decreased neurogenesis, including elevated levels of 
neuroinflammation and oxidative stress, both of which have been shown to be 
induced by HFD feeding (Boitard et al, 2012; Lindqvist et al., 2006; Pistell et al, 
2010; Tozuka et al, 2009).  
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2.1.5 Brain-Derived Neurotrophic Factor (BDNF) 
Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays an 
important role in the growth, maintenance, and survival of many types of neurons 
(Kanoski and Davidson, 2011). BDNF is present in the hippocampus, and 
disruptions in the neurotrophin, or its receptor, can reduce hippocampal synaptic 
plasticity and neurogenesis, both of which have been postulated to underlie 
hippocampal-dependent learning and memory (Kanoski and Davidson, 2011). In 
effect, research has shown that consumption of diets high in fat and refined sugars 
decreased the level of BDNF in the hippocampus of rats, and that this decrease was 
accompanied by decreased synaptic plasticity, as well as decreased performance in 
tests of hippocampal-dependent memory (Molteni et al, 2002; Stranahan et al, 
2008). Molteni et al (2004) have also shown that the decrease in hippocampal-
dependent memory performance as a result of HFD could be prevented by voluntary 
exercise, and that this improved performance was associated with an increase in 
BDNF and its downstream signalling molecules relative to animals that did not 
exercise. Thus, BNDF does appear to play a modulating role in the relationship 
between the consumption of a Western diet, and resulting cognitive deficits.  
3.0 Maternal Obesity 
In parallel with the increase in obesity worldwide has been an increase in the 
number of obese women of reproductive age. Indeed, in 2012, roughly 45% of 
Canadian women over the age of 18 were classified as overweight, or obese 
(Statistics Canada, 2013). In developed countries, over 60% of women of 
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childbearing age are overweight (Rodriguez et al, 2012). Obesity is associated with 
an increase in pregnancy-related complications, including gestational diabetes and 
preterm delivery, increased complications during labor and delivery, as well as 
difficulties for both the mother and offspring postpartum (Hanson et al, 2012). 
Animal studies corroborate human data, and indicate that maternal obesity can 
indeed have a significant negative impact on offspring development, both at the 
level of peripheral physiology, as well as the central nervous system. Importantly, in 
both the F0 and F1 generations, the cognitive effects of obesity have been 
predominantly studied in male animals, and, given that the effects do seem to be 
sex-specific, we currently have a relative dearth of information concerning effects 
on the female brain. 
3.1 Developmental Origins of Health and Disease (DOHaD) 
The idea that the maternal environment can lead to disruptions in the 
offspring phenotype is commonly referred to as the Developmental Origins of 
Health and Disease Theory (DOHaD), and its origins are most commonly associated 
with work done by Barker and colleagues after a series of epidemiological studies of 
birth and death records that revealed a high geographic correlation between rates of 
infant mortality and certain classes of later adult deaths, as well as an association 
between birthweight and rates of adult death from ischemic heart disease (Wadwha 
et al., 2009). Notions of the theory were articulated even earlier, however, by 
Forsdhal, who used Norwegian statistical data to show that early-life poverty 
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followed by prosperity was associated with increased risk of death from coronary 
heart disease (Brenseke et al, 2013).  
The DOHaD theory proposes that the fetus uses the maternal environment as 
a proxy for the environment into which it will be born, and “adapts” its physiology 
to best be able to thrive in its predicted environment. Problems arise, however, 
when the post-natal environment is not well matched to what was predicted, and 
irreversible physiological adaptations made by the fetus in pregnancy predispose to 
disease. Much work has since been done to elucidate the influence of maternal 
nutritional environment on offspring development. 
Although the bulk of work concerning DOHaD was originally focused on 
maternal undernutrition, the current global nutritional environment has led to a 
shift in focus to overnutrition. Paradoxically, some of the same characteristics of the 
metabolic syndrome seen in offspring born to undernourished mothers occur in 
those born to obese mothers, suggesting a U-shaped curve for optimal maternal 
energy environment. 
3.2 Metabolic effects in offspring  
Children of obese women have increased BMI, body fat percentage, and 
insulin resistance, and high-fat-fed dams produce offspring with insulin resistance, 
increased fat deposition, and elevated circulating leptin at birth (Bilbo and Tsang, 
2010). The offspring are thus primed to develop the metabolic syndrome and its 
associated complications, a particularly concerning phenomenon considering the 
obesogenic environments in which we live, and the potential negative effects that 
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obesity can have on the developing organism. In addition to the increased risk of 
somatic sequelae, maternal overnutrition has been shown to induce changes in 
central energy balance and appetite regulation, principally via disruptions of the 
hypothalamic neurocircuitry that regulate feeding behavior (Bouret, 2009). An 
increased risk of metabolic complications combined with a propensity towards 
energy dysregulation and a lack of appetitive control represents a “double hit” for 
these individuals, who will then struggle with weight regulation despite even the 
best intentions. 
3.3 Effects on Offspring Cognition 
In both human and animal studies, maternal obesity, as well as obesity in 
childhood (given that the offspring of these mothers are more likely to be obese 
themselves), has also been associated with cognitive disruption. For example, a 
prospective clinical study of maternal obesity outcomes reported high inattention 
scores and a two-fold increase in risk of difficulties with emotional regulation in 5-
year-old children (Rodriguez et al, 2012). Another study showed that obese children 
had lower BDNF levels (El-Garbway et al, 2006), and performed worse on D2 and 
Wisconsin tests (tests of attention and mental flexibility, respectively) (Cserjesi et al, 
2007).  
In animal models, maternal obesity causes developmental abnormalities in 
both hypothalamic and hippocampal brain regions, as well as disruptions in the 
serotonergic, dopaminergic, and opioid systems, which result in increased anxiety, 
impairment in learning and memory, and desensitization of reward systems 
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(Rodriguez et al, 2012). For example, Peleg-Raibstein et al (2012), showed that 
maternal exposure to a high-fat diet for 9 weeks resulted in offspring that displayed 
increased anxiety-like behaviors, as indicated by performance in the elevated plus 
maze and food neophobia, while conditioned fear response and exploratory 
behavior remained unaffected. The same study showed that such changes were 
associated with changes in GABAergic, and serotonergic receptors, as well as BDNF 
levels, in the hippocampus of offspring of high fat diet-fed dams. Another group also 
showed increased anxiety in HFD pups, although these animals also showed 
facilitated acquisition of a MWM task with respect to controls (Bilbo and Tsang, 
2010). The observations were accompanied by increased pro-inflammatory 
cytokines and levels of microglial activation in the hippocampus. Interestingly, 
Rodriguez et al (2012) showed that offspring born to high-fat diet-fed dams had 
decreased anxiety in an open field test, but found no group differences in an 
elevated plus maze. This group also showed learning impairment in the HFD group 
in a test of operant conditioning, and this effect was not prevented by switching 
dams to a control diet prior to gestation and lactation. 
As in studies of obesity in adulthood, the interpretation and comparison 
across studies is complicated by the heterogeneity of experimental protocols, 
although it seems clear that developmental disruption does indeed occur at the level 
of the hippocampus in offspring born to HFD-fed mothers, and thus that an obese 
maternal environment is able to adversely affect this brain region.  
4.0 The Hippocampus 
14 
 
The hippocampus is a limbic structure that is well known for its role in 
learning and memory, and is located in the medial temporal lobe of both 
hemispheres. The structure plays a role in the consolidation of memories, as well as 
in spatial navigation and learning. The morphology of the hippocampus is well 
defined, and consists of the dentate gyrus, Ammon’s horn, and the subiculum; the 
structure’s highly organized nature, as well as its relatively conserved and 
straightforward anatomy, has allowed for its extensive use in the study of 
neurophysiological phenomena.  The hippocampus has been shown to be a brain 
region particularly susceptible to a variety of insults and is, in fact, one of the first 
brain structures to be affected in Alzheimer’s disease and other dementias (Kanoski 
and Davidson, 2011). As we have seen, the hippocampus is also a prime target of 
obesity-related disturbances in the brain.  
4.1 Long-Term Potentiation 
Long-Term Potentiation (LTP) is a cellular mechanism underlying learning 
and memory, and has been particularly well-studied in the hippocampus. The 
phenomenon can be described as an increase in synaptic efficiency following a brief 
train of high frequency stimulation (HFS) (Gerges et al, 2003), and many of the 
molecular events that occur with LTP have also been shown to occur with learning 
and memory (for a review, see Lynch, 2004). Perhaps some of the strongest 
evidence for the role of LTP in learning and memory, however, comes from studies 
showing LTP-like changes in the behaving animal subsequent to learning. Indeed, 
studies using implanted electrodes in area CA1 of the hippocampus have shown that 
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the acquisition of hippocampal-dependent tasks is accompanied by the potentiation 
of synaptic responses that last for several hours (Gruart et al, 2006; Whitlock et al, 
2006). Like LTP, this potentiation was shown to be NMDA-receptor-depedent 
(Gruart et al, 2006), and was occluded by HFS-induced potentiation (Whitlock et al, 
2006), providing strong evidence for the occurrence of LTP in the behaving animal. 
Moreover, inhibition of LTP has been shown to disrupt hippocampal-dependent 
learning and retention (Morris et al, 1986). LTP in the CA1 hippocampal region has 
been shown to be attenuated in genetic animal models of obesity (Gerges et al, 
2003; Li et al, 2002), as well as in nutritionally-induced models of obesity (Hwang et 
al, 2010; Porter et al, 2011; Stranahan et al, 2008). Conversely, Mielke et al (2006) 
did not see differences in hippocampal LTP in mice fed a HFD for one year, or in 
fructose-fed hamsters (Mielke et al, 2005, 2006). 
Interestingly, Porter et al (2011) showed that the deleterious effects of HFD 
on LTP in the CA1 hippocampal region could be reversed by administration of 
glucose dependent insulinotropic peptide (GIP), which improves glucoregulation, 
suggesting that glucose homeostasis plays a role in this phenomenon. As well, Farr 
et al (2008), have shown that triglycerides, which are normally elevated in the 
serum of obese individuals, can impair maintenance of the NMDA component of 
hippocampal long term potentiation. Only one study has looked at sex-differences, 
and showed decreased hippocampal LTP in male, but not female mice (Hwang et al, 
2010), which is consistent with the literature, as male animals do seem to be more 
susceptible to the deleterious effects of a high-fat diet than female ones. 
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Additionally, to our knowledge, LTP in the hippocampus of offspring born to HFD-
fed mothers has not yet been explored.  
5.0 Study 1  
Our first study explored the effects of a four-month feeding protocol on 
synaptic function in adult female rats and their offspring. We measured body 
weight, food consumption, and oral glucose tolerance throughout the feeding 
period. Upon sacrifice, a series of terminal biometrics were collected, including 
retroperitoneal fat pad weight as a measure of adiposity. Finally, LTP was measured 
in the CA1 region of hippocampal slices acutely prepared from animals in each 
group.   
5.1 Methods 
5.1.1 Animals and Diets 
Female, non-sibling Sprague-Dawley rats were received at post-natal day 
(PND) 21 and housed in polypropylene cages with woodchip bedding and stainless 
steel wire lids. Animals were fed Harlan Teklad rodent diet ad libitum with free 
access to water until PND56, at which point they were randomly assigned to HFD 
and control diet (CD) groups. Rats were placed on either a HFD (20% protein, 35% 
carbohydrate, 45% fat; Research Diets D12451), or CD (20% protein, 70% 
carbohydrate, 10% fat; Research Diets D12450B) ad libitum for 16 weeks (See 
Appendix for full details of diet composition). Animals were kept on a 12-hour 
dark/light cycle in groups of 3 rats per cage. Food and body weights were collected 
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weekly throughout the 16-week feeding period. Food consumption was recorded as 
mass (in grams) of food consumed by each group of rats, weekly. 
5.1.2 Oral Glucose Tolerance Testing 
Oral glucose tolerance tests (OGTTs) were performed at 4, 8, 12, and 16 
weeks on the diet. Animals were fasted for 10-12 hours prior to being gavaged with 
a 50% glucose solution (4 g/kg). Blood glucose measurements were taken at 
baseline, and at 30, 60, 90, and 120 minutes after glucose administration via a tail 
poke, using a standard glucose meter. Area under the curve (AUC) was then 
calculated for each animal to give an overall measure of glucose tolerance.  
5.1.3 Terminal Biometrics 
Two of the three animals from each cage were decapitated following a 12-
hour fast and anaesthesia induced with CO2. Fasting blood glucose was measured 
from trunk blood using a standard glucose meter. Spleen, liver, adrenal glands, and 
retroperitoneal fat pads were excised and weighed. Liver volume was also 
measured.  
5.1.4 Electrophysiology 
5.1.4.1 Hippocampal Extraction and Slice Preparation 
After sacrifice, each brain was quickly removed and placed in chilled 
oxygenated (95% O2:5% CO2) artificial cerebrospinal fluid (aCSF; ≤4°C; composition 
127.0 mM NaCl, 2.0 mM KCl, 1.2 mM KH2PO4, 26.0 mM NaHCO3, 2.0 mM MgSO4, 2.0 
mM CaCl2, 10.0 mM glucose; pH 7.37-7.43; osmolality 300-320 mOsm). One 
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hippocampus was extracted (the right hippocampus was preferred) and cut with a 
McIlwain tissue chopper into 350 µm thick slices. Slices were then incubated on a 
microfilter and allowed to recover at interface for a minimum of 1 hour in a 
chamber with warm aCSF (35°C) and flowing carbogen (95% O2:5% CO2) prior to 
the start of experiments.  
5.1.4.2 Field Potential Recording 
Field excitatory postsynaptic potentials (fEPSPs) were recorded by placing 
the recovered hippocampal slice onto a 8 x 8 multi-electrode array probe (electrode 
size: 50 x 50 µm, and inter-electrode distance: 100 µm). The fEPSPs were sampled 
using the MED64 system (Alpha MED Scientific Inc., Osaka).  Slices were placed on a 
probe, immersed in warmed aCSF, and immobilized by a mesh and anchor. The 
probe was connected to a perfusion system running at 1.6 mL aCSF/min.  After 20 
minutes of stabilization, points for Schaffer collateral stimulation were selected, 
with the recording point always located in the CA1 dendritic field. Figure 1 shows a 
slice placed on the micro-electrode array. 
5.1.4.3 I-O curve 
An input-output curve (IO) was made to determine the stimulation intensity 
needed to evoke a response eliciting 30-50% of the maximal fEPSP amplitude. To 
measure the input-output relationship, fEPSP amplitudes were recorded against 
increasing stimulation intensities at increments of 5 μA, with each biphasic pulse 
lasting 0.2 ms. Maximum fEPSP amplitude was defined as occurring immediately 
before the waveform showed contamination from other sources (i.e., a population 
spike). Because of the variation in the degree of contact between the probe and each 
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individual slice, as well as the responsiveness of each individual slice, slices tend to 
show variation in the minimum intensity at which they display a response. For 
analysis purposes, the point at which each slice shows first shows a response was 
denoted point 1, and each subsequent point is 5 μA greater than the previous point.  
5.1.4.4 Long-Term Potentiation 
   A control period of baseline activity was recorded for a minimum of 20 
minutes before application of a tetanus (two trains of 1 s, 100 Hz, 20 s apart).  Field 
potentials were recorded for 30 minutes post-HFS, and potentiation was measured 
as an average of the last 5 minutes of recording, taken as a percentage of the 
baseline average.  
5.1.5 Breeding Protocol 
At the end of the 16-week feeding protocol, the third rat from each cage was 
bred with a male Sprague-Dawley rat. Pregnant dams continued to be fed their 
respective diets (CD, or HFD) throughout gestation and lactation. Litters were kept 
between 4-8 pups in order to control for the variability in nutrition and maternal 
care received by each pup in litters of varying sizes. Litters with more than 8 pups 
were culled to 8, and litters with less than 4 pups were not included in the analyses. 
At PND 21, all pups were weaned onto CD, and male and female animals from each 
litter were separated and housed in groups of 2-4 animals per cage. Body weights 
were monitored once weekly. Pups were maintained on the CD until young 
adulthood (PND 56), at which point they were sacrificed for analyses. Figure 2 
shows a schematic of the general experimental timeline.  
5.1.5.1 Oral Glucose Tolerance Testing 
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 Pup OGTTs were performed once at preadolescence (PND 28), and once at 
young adulthood (PND 56), as described for the maternal generation (Section 5.1.2). 
5.1.5.2 Terminal Biometrics 
 Animals were sacrificed at young adulthood (PND 56-70) in the same manner 
as the maternal generation, and the same terminal biometric measurements were 
completed (see section 5.1.3). 
5.1.5.3 Electrophysiological recordings 
 Hippocampal slice preparation and experimental protocols for 
electrophysiological measures were conducted exactly as described for the maternal 
generation (see section 5.1.4). 
5.1.6 Data Analysis 
All data were analyzed via unpaired, two-tailed t-tests using GraphPad Prism 
software, except for the slice ratio data, which were analyzed with a chi square test. 
Suspected outliers were subjected to the Grubb’s test, and removed if deemed to be 
significant.  
*Note: Study 1 was conducted in two rounds, over a period of two years. I arrived in 
the lab prior to the commencement of the second round of the study, and thus was 
only involved in part of the data collection. I did, however, perform the data 
extraction and analysis for both sets of data. The data presented here are a 
combination of both cohorts (as the studies were exact replicates of one another), in 
order to allow for an increased sample size.  
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5.2 Results 
5.2.1 Maternal Generation 
5.2.1.1 Body Weight and Food Consumption 
Weight tracking data revealed no differences in body weight between the CD 
and HFD groups over the duration of the feeding period (Table 1; Figure 4). As well, 
beginning from the second week on the diet, HFD animals consumed significantly 
less food by weight (weeks 2-12, P<0.01; weeks 13-15, P<0.05; Figure 5), but more 
food by energy (weeks  1, 8, 11, and 14, P<0.05; Figure 6), than CD animals . 
5.2.1.2 Oral Glucose Tolerance  
Results showed statistically significant differences between HFD and CD 
groups as early as one month on the diet (CD AUC: 341.0 ± 21.76, N=19; HFD AUC: 
424.0 ± 23.48, N=17; P = 0.0138, t=2.60, df=34), and at each subsequent timepoint 
until sacrifice (8 weeks CD AUC: 279.1 ± 15.67, N=20; HFD AUC: 359.7 ± 16.58, 
N=19; P=0.0011, t=3.54, df=37; 12 weeks CD AUC: 268.1 ± 11.28, N=20; HFD AUC: 
350.8 ± 20.87, N=20; P=0.0013, t=3.48, df=38; 16 weeks CD AUC: 234.7 ± 11.02, 
N=20; HFD AUC: 290.9 ± 15.7, N=20; P=0.0057, t=2.93, df=38). Figure 7 shows a 
summary of the OGTT data across the feeding period. Data are mean ± SEM.  
5.2.1.3 Terminal Biometrics 
Significant differences were found only for retroperitoneal fat pad weight 
(CD: 0.4776 ± 0.02224; HFD: 0.6273 ± 0.03751; P=0.0015, t=3.43, df=38). Results 
showed no differences between groups in fasting blood glucose, spleen weight, liver 
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weight, liver volume, or adrenal gland weight (Table 2). Figure 8 shows a graphical 
representation of the fat pad weight data. 
5.2.1.4 I-O Curve 
Baseline synaptic transmission, as measured by an input-output curve, did 
not differ between groups (Figure 9).  
5.2.1.5 Long Term Potentiation  
Results showed a significant impairment in potentiation in the HFD group 
(CD:  138.6% +/- 3%; HFD: 127.6% +/- 1.5%; P=0.0064, t=3.03, df=21; Figure 10). 
The same data are presented in Figure 11a as a bar graph, along with the 
corresponding results for slope (Figure 11b), which followed the same pattern of 
impairment in HFD animals (CD: 149.6% ± 6.4%; HFD: 132.3% ± 3.9%; P=0.045, 
t=2.14, df=21). Data are mean ± SEM. Figure 12 shows a set of representative traces 
both before and after HFS, for both diet groups.  
5.2.1.6 Ratio of Slices Displaying Potentiation  
Given that we set a 20% threshold for potentiation (i.e., slices that did not 
show a minimum of 20% potentiation above baseline were not included), we report 
the ratio of the number of slices that showed potentiation to the total number of 
slices that displayed a stable baseline (i.e., slices exhibiting robust baseline synaptic 
transmission). There were no diet-induced differences in the proportion of slices 
displaying potentiation versus those with a stable baseline (P=0.667, χ²=0.186, 
df=1). The data is shown in table 3.  
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5.2.2 Pup Generation 
5.2.2.1 Offspring Body Weight 
Female HFD offspring were significantly heavier than their CD counterparts 
at PND 35 (CD: 117.4g ± 1.7g; HFD: 127.1g ± 1.4g; P=0.0048, t=4.35, df =6) and PND 
42 (CD: 150.1g ± 1.4g; HFD: 161.4g ± 2.7g; P=0.0104, t =3.67, df=6), and the trend 
remained until sacrifice at PND 56 (Figure 13b). There were no significant 
differences in body weight in male offspring at any time point (Figure 13a).  Data are 
mean ± SEM. 
5.2.2.2 Oral Glucose Tolerance  
There were no diet-induced differences in oral glucose tolerance in the 
offspring of either sex, at any time point (Figure 14). 
5.2.2.3 Terminal Biometrics 
There were no significant differences in FBG, spleen weight, liver weight, 
liver volume, adrenal gland weight, or retroperitoneal fat pad weight in CD versus 
HFD offspring of either sex (Tables 4 and 5).  
5.2.2.4 I-O Curves 
There were no diet-induced differences in baseline synaptic transmission, as 
measured by input-output curves, in offspring of either sex (Figure 15).  
5.2.2.5 Long-Term Potentiation  
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There were no diet-induced differences in potentiation of either amplitude, 
or slope in male offspring (Figure 16). Figure 10 shows a summary of the magnitude 
of potentiation of both amplitude (17a) and slope (17b) in both diet groups.  
5.2.2.6 Successful Slice Ratio 
Although there were no significant diet-induced differences in the successful 
slice ratio in offspring of either gender (males: P=0.886, χ²=.0204, df=1; females: 
P=0.201, χ²=1.636, df=1), the female HFD offspring had a considerably lower 
success ratio than their CD counterparts (CD: 62.5%; HFD 14.3%; Table 7). The 
success ratio in this group was so low that, after the exclusion of all slices that did 
not meet the threshold for potentiation there was insufficient data to run statistical 
comparisons between the diet groups in the female offspring. LTP data are therefore 
only presented for male offspring.  
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5.3 Discussion 
Maternal Generation 
To my knowledge, this is the first study to show decreased hippocampal LTP 
in female animals as a result of HFD-feeding. Several other studies have shown a 
similar reduction in male animals (Farr et al, 2008; Hwang et al, 2010; Lennox et al, 
2014; Porter et al, 2011; Stranahan et al, 2008), although this is not always the case 
(Mielke et al, 2006). Mielke et al (2006) fed male mice the same diet used in the 
present study for a period of one year and did not report changes in LTP; the 
difference may be an age effect, for LTP is known to decrease with age (Blau et al, 
2012) and the mice were considerably older than our rats (one year vs. six months 
of age, respectively). As well, Hwang et al (2010) were the only other group to 
examine the effect of sex, and they did not find differences in LTP in female mice as a 
result of HFD-feeding, although they did find a difference in male animals. Notably, 
these mice were approximately the same age, and of the same strain as those used 
by Mielke et al (2006), and both groups fed their animals for similar time periods 
(Mielke et al (2006) fed for one year, and Hwang et al (2010) fed for 9 months to 
one year). It is difficult to speculate about the source of the differences in the 
findings because Hwang et al (2010) do not report the composition of their HFD. 
The possibility therefore exists that the concentration of saturated fats and/or 
refined sugars was elevated with respect to the diet used by Mielke et al (2006), and 
that more drastic impairments were seen as a result. Nevertheless, the lack of an 
effect in female animals in the study by Hwang et al (2010) may indeed be the result 
of a floor effect due to the advanced age of the animals, given that spatial memory 
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performance (which is tightly associated with hippocampal LTP; Malenka and 
Nicoll, 1999) is known to differ between sexes across the lifespan (Bucci et al, 
1995). We may therefore have been able to detect an effect because we sampled the 
animals earlier in the lifespan, although differences in species and diet composition 
cannot be discounted.   
Interestingly, the impairments we saw in hippocampal LTP were not 
accompanied by differences in body weight, although we did see increased adiposity 
and impaired glucose tolerance in the animals. The lack of a difference in body 
weight may be due, in part, to the fact that female animals are generally less 
susceptible to the metabolic effects of a HFD (Hwang et al, 2010). Another reason 
may be the composition of our control diet, which, being relatively high in refined 
sugars (35% sucrose by energy in the CD, whereas this proportion was only 17% in 
the HFD), may have masked our ability to detect significant differences in body 
weight. The presence of moderately elevated concentrations of refined sugars in the 
control diet, and the presence of a diet-related difference, potentially speaks to the 
particularly detrimental effects of high concentrations of dietary saturated fats.  
Indeed, Farr et al (2008) specifically investigated the effects of fats on spatial 
memory by demonstrating that daily administration of gemfibrozil, a drug that 
lowers triglycerides, for two weeks, rescued the performance of the HFD mice on a 
T-maze foot shock avoidance task. To confirm the specific effects of triglycerides, 
Farr et al (2008) directly administered the triglyceride triolein into the 3rd ventricle 
and found that this impaired performance on the T-maze. The authors further 
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extended the investigation of the effects of triglycerides on hippocampal function by 
showing that direct application of triglycerides to hippocampal slices abolished both 
the induction and maintenance of LTP, and did so by reversibly inhibiting the NMDA 
component of the fEPSP. 
 Although we did not measure plasma triglycerides, hypertriglyceridemia is a 
component of the metabolic syndrome that is often seen with increased adiposity 
and insulin resistance (Subramanian and Chait, 2012), and has been previously seen 
in rodents with diet-induced obesity (Banks, 2004). Hypertriglyceridemia therefore 
represents a potential mechanism for the impairments observed. The reversibility 
of the effects seen by Farr et al (2008) are also in agreement with the biochemical 
data from our study (completed by another student), which showed no differences 
in hippocampal NMDA receptor subunit expression between groups (Pavlov, 2013); 
a transient effect on NMDA receptor function would not likely manifest as a 
difference in subunit expression, but instead as a functional change (e.g., 
phosphorylation).   
Saturated fatty acids have also been shown to disrupt brain function via 
central inflammatory processes (Milanski et al, 2009). Indeed, obesity is recognized 
as a state of chronic, low-grade inflammation, which is thought to be, at least in part, 
responsible for the insulin and leptin resistance seen in these individuals (Miller and 
Spencer, 2014). Milanski et al (2009) show that, in the hypothalamus, saturated 
fatty acids are able to bind to Toll-like receptor 4 (TLR4), a component of the innate 
immune system expressed primarily on microglia in the brain. The binding activates 
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microglia, causing them to secrete pro-inflammatory cytokines, which promote 
endoplasmic reticulum stress (ER stress) (Milanski et al, 2009). Both inflammation 
and ER stress promote oxidative stress, which, in turn, feeds back to promote 
inflammation in a vicious positive feedback loop (Miller and Spencer, 2014). The 
possibility exists that the saturated fatty acids in a HFD activate the TLR4 in the 
hippocampus as well, leading to similar consequences, and ultimately cognitive 
disruption. Indeed, increased microglial activation and TLR4 expression in the 
hippocampus have been seen as a result of HFD feeding (Bilbo and Tsang, 2010), 
and HFD-induced central inflammation has been suggested to impair cognition 
(Pistell et al, 2011), although both of these cited studies used a higher concentration 
of saturated fat than was present in our HFD (60% vs 45%, respectively). The high 
saturated fat content of our HFD may have, nonetheless, provoked central 
inflammatory processes and oxidative stress in the animals, leading to impairments 
in hippocampal function. A schematic summarizing this proposed mechanistic 
pathway is presented in figure 3.  
In agreement with this mechanistic pathway, Lennox et al (2014) showed 
that the LTP impairment they observed as a result of HFD-feeding was restored by 
an intervention that reduced markers of central inflammation and oxidative stress 
(i.e., administration of a GLP-1 receptor agonist for 20 days), and that this was 
accompanied by improved performance on an object recognition task, which is 
hippocampal-dependent.  Previous studies have also shown that both behavioral 
and pharmacological interventions that reduce central oxidative stress (Molteni et 
al 2004; Wu et al, 2004) and inflammation (Jeon et al, 2012; Lu et al, 2011) in the 
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context of HFD-feeding also restore hippocampal-dependent memory.  Moreover, 
the results by Lennox et al (2014) were seen without the normalization of body 
weight (i.e., the HFD animals were heavier than their CD counterparts even after 
treatment, when their hippocampal function was no longer impaired), providing 
further evidence that differences in body weight alone are not directly responsible 
for differences in hippocampal function between animals.  
Erion et al (2014) further demonstrate the importance of adiposity (as 
opposed to body weight) on brain function by demonstrating that impairments in 
both cognition and hippocampal LTP in leptin-insensitive mice (i.e., db/db mice; a 
genetic model of obesity) are reversed by interventions that reduce adipose tissue, 
and that this is mediated by IL-1β, a pro-inflammatory cytokine that is released by 
adipose tissue in obese individuals. The relevance of these findings is twofold. First, 
they support the notion that differences in adiposity may be a more sensitive 
predictor of obesity-related cognitive impairment than differences in body weight.  
Second, they suggest that obesity-related cognitive deficits are a function of 
inflammatory processes at least partly driven by excess adipose tissue, and not of 
defective leptin-receptor signalling per se, given that cognition was rescued in these 
animals by decreasing adiposity without restoring leptin receptor function (Erion et 
al, 2014). Therefore, because we saw increased adiposity in our animals, peripheral 
inflammation may also have driven and/or contributed to the disruptions in 
hippocampal function seen. In addition, blood-brain barrier integrity is 
compromised in the obese state (Kanoski et al, 2010), and this may allow increased 
access of peripheral cytokines into the brain, further propagating central 
30 
 
inflammatory stress in a process of cytokine-mediated cytokine release (Miller and 
Spencer, 2014). 
The mechanisms whereby inflammation can affect brain function have not 
yet been fully elucidated, although both direct and indirect mechanisms have been 
posited. Elevated concentrations of pro-inflammatory cytokines in the brain can 
directly promote neurodegeneration and beta-amyloid formation, one of the 
hallmarks of Alzheimer’s disease (Miller and Spencer, 2014), and are also likely to 
affect neurogenesis and synaptic plasticity, at least in part through their actions on 
neurotrophins that mediate these processes.   
One such neurotrophin is BDNF, which is known to regulate synaptic efficacy 
via its actions on proteins that regulate synaptic function (Molteni et al, 2002). 
BDNF plays a role in the conversion of electrical activity into changes in synaptic 
strength (Panja and Bramham, 2014; Poo, 2001; Schnider and Poo, 2000) and has 
been shown to have a facilitative role in LTP (Panja and Bramham, 2013). For 
example, BDNF knockout mice are significantly impaired in hippocampal CA1 LTP 
and recombinant-BDNF treatment of slices from these mice returned LTP to wild-
type levels (Patterson et al, 1996). HFD has consistently been shown to 
downregulate hippocampal BDNF (Kanoski et al, 2007; Molteni et al, 2002; Park et 
al, 2010), and this has been seen concomitantly with increased oxidative stress 
(Molteni et al, 2004) and inflammation (Pistell et al, 2011). Stranahan et al (2008) 
also showed that HFD-induced impairments in hippocampal LTP were accompanied 
by reductions in both hippocampal BDNF, as well as dendritic spine density. 
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Moreover, interventions that prevent the diet-induced decreases in BDNF and its 
downstream effectors have been shown to prevent spatial memory impairments in 
the MWM (Molteni et al, 2004).  
Taken together, the evidence suggests that, in our animals, a high-fat diet led 
to increased inflammation and oxidative stress, which may have ultimately reduced 
hippocampal BDNF and downstream synaptic plasticity, leading to the observed 
impairments in LTP. Figure 3 shows a summary schematic of the hypothesized 
mechanistic pathway. We cannot be sure of this mechanism, however, given that we 
did not include measures of central inflammation, oxidative stress, or neurotrophins 
in our study. Moreover, although our results reached significance, the magnitude of 
the reduction in LTP that we observed was modest, and our lack of behavioral 
measures prevents us from making conclusions about the biological significance of 
the results (i.e., whether they would be accompanied by impairments in 
hippocampal-dependent memory). Future studies should aim to include measures 
of each of these factors in the same study to tease apart the mechanisms underlying 
HFD-induced cognitive impairment. In addition, the studies cited above vary 
considerably in important ways from both each other and the current study. 
Differences in species, strain, sex, diet composition, and feeding length all 
compromise the generalizability of the studies, and the ability to compare between 
them. Future research attempt to control for these factors in order to more 
systematically assess the effects of obesity on cognition. 
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Offspring Generation 
The second portion of our study involved the offspring generation, which had 
only been exposed to the HFD through their mothers (i.e., 3 weeks of gestation and 3 
weeks of lactation). An important point is that siblings from the same litter were not 
counted as individual data points, and thus, even with 100% breeding success, the 
maximum possible sample size for the offspring generation would have been N = 10 
litters per diet condition (5 from each round of the study). Given the limited success 
we had with breeding, however, the actual sample sizes were lower.   
Although offspring born to HFD dams tended to be heavier than their CD 
counterparts, we did not see any significant differences in glucose tolerance, or 
retroperitoneal fat pad weight. The apparent lack of a metabolic difference is 
contrary to what is found in the literature, which suggests that maternal obesity 
induces obesity and related metabolic impairments in offspring (for a review, see Li 
et al, 2011). Because the maternal generation did exhibit significant metabolic 
alterations as a result of HFD feeding, the lack of a significant difference between 
members of the offspring generation is likely the result of insufficient sample size. 
Indeed, the results from our OGTT procedure are inherently variable, and thus a 
larger sample size is required. Moreover, despite our small sample size (N=4), we 
did observe trends towards increased body weight in offspring of both sexes, 
suggesting that differences are indeed present, and that increasing the sample size 
would serve to emphasize these differences.  
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To my knowledge, this is the first study to investigate hippocampal LTP in the 
offspring of HFD-fed mothers, although previous studies do suggest that 
hippocampal function is disrupted in offspring as a result of maternal obesity (Bilbo 
and Tsang, 2010; Niculescu and Lupu, 2009; Page et al, 2014; Peleg-Raibstein et al, 
2012; Sasaki et al, 2013, 2014; Tozuka et al, 2009, 2010; Walker, 2008; White et al 
2009). Specifically, previous studies have shown impaired spatial memory 
performance (Page et al, 2014; Tozuka et al, 2010; White et al, 2009), increased 
hippocampal inflammation (Bilbo and Tsang, 2010; Sasaki et al, 2014) and oxidative 
stress (Tozuka et al, 2009, 2010), as well as decreased neurogenesis and plasticity 
(Niculescu and Lupu, 2009; Tozuka et al, 2009, 2010). As with the parental 
generation, however, considerable variability between experimental protocols 
makes comparing across studies difficult, and interferes with the ability to make any 
definitive statements about the effects of maternal obesity on offspring brain 
function.  
Taken together, the literature suggests that LTP might also be impaired in the 
offspring of obese mothers. Despite this, we found no differences in potentiation 
between groups after excluding slices that did not meet our 120% potentiation 
threshold for LTP. Again, our small sample size likely led to a level of power 
insufficient to detect significant differences, particularly given the relatively modest 
effect size seen in the maternal generation. Of potential significance, however, the 
ratio of successfully potentiated slices in female offspring was considerably reduced 
in the HFD group (Table 8). The possibility exists that this was a result of the 
maternal diet almost completely abolishing LTP in these animals, although this 
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possibility should be interpreted with caution given the limited sample size and lack 
of behavioral data measuring memory in the intact animal.  
Overall, drawing firm conclusions with respect to the offspring generation is 
difficult due to the limited sample size. Future iterations of the study should seek to 
optimize the breeding environment to increase breeding success, as well as 
incorporate behavioral measures of hippocampal memory (e.g., Morris Water Maze) 
in order to test the biological significance of any conclusions drawn from LTP data.  
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6.0 Study 2  
The purpose of study 2 was to extend upon the findings of study 1, as well as to 
explore some of the mechanistic questions that arose. Although the 
electrophysiological assays remained the same, behavioral measures and 
biochemical measures of inflammation were performed by other students. The 
design was similar to that of study 1, although some important changes were made 
to the feeding protocol: 
1) As opposed to starting the animals on their diets at young adulthood (PND56, 
as per study 1), animals were randomly assigned to either HFD or CD at 
PND28, an age at which rodents are still considered to be in adolescence.  
2) The composition of the CD was changed such that the carbohydrate source 
was primarily complex carbohydrate as opposed to simple sugars (0% 
sucrose in study 2 versus 35% sucrose in study 1; see appendix for the exact 
composition of the diets in each study).  
3) The feeding protocol was shortened from 16 weeks to 10 weeks. 
The decision to put the animals on their respective diets at an earlier timepoint 
was based on data from the literature, suggesting that younger animals are more 
vulnerable to the effects of HFD feeding than their adult counterparts (Boitard et al, 
2012, 2014; Hwang et al, 2010), which seems intuitively plausible, given that 
disturbances to the physiological milieu are more likely to be disruptive while 
development is still underway than after the majority of development has taken 
place. Moreover, the shift lent ecological relevance to the study, as it is likely that 
36 
 
obese individuals are not exclusively exposed to their obesogenic diets in adulthood, 
but over the course of their early lives as well. We hypothesized that, despite the 
shorter exposure to the diet, we would see more dramatic changes (particularly in 
body weight, where we saw no significant changes in study 1) in the HFD animals.  
The decision to shorten the feeding period was both a practical one, and one that 
was supported by the literature, suggesting that similarly brief feeding periods 
affected both metabolic and cognitive function when the diet was administered 
during development (Boitard et al, 2012). Moreover, we suspected that eliminating 
the refined carbohydrate content from the CD would further serve to emphasize the 
impairments due to HFD exposure.  
Notably, although study 2 also had a breeding component incorporated into the 
study design, the timing of the experiments were such that the data collection for 
the offspring generation of study 2 would not be complete in time for inclusion in 
my thesis document. As a result, only the data for the maternal generation of study 2 
are presented here.  
6.1 Methods  
6.1.1 Animals and Diets 
Female, non-sibling Sprague-Dawley rats were received at PND 21 and 
housed as described in study 1. The animals were permitted to acclimatize for one 
week while being fed the Haran Teklad rodent diet ad libitum, after which (PND 28) 
they were separated into the HFD and CD groups. The HFD was the same as in study 
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1 whereas the CD diet was replaced with a control diet similar in all respects, except 
that the sucrose was replaced by complex carbohydrate. The diets were fed ad 
libitum for 10 weeks, with body weights and food consumption collected as 
described for study 1.  
6.1.2 Oral Glucose Tolerance Tests 
Oral glucose tolerance tests (OGTTs) were performed after 4 and 8 weeks on 
the diet as described for the animals in study 1.  
6.1.3 Terminal Biometrics 
Spleen, liver, adrenal glands, and retroperitoneal fat pads were excised and 
weighed as described for study 1, with the exception of the 12-hour fast. The 
animals in this study were not fasted prior to sacrifice, in order to reduce stress.   
6.1.4 Electrophysiology 
Slice preparation and electrophysiological recordings were performed 
exactly as described in study 1, except that the I-O curves increased at intervals of 2 
µA, as opposed to 5 µA. 
6.2 Results 
6.2.1 Body Weight and Food Consumption 
HFD animals were heavier than CD animals as early as one week on the 
respective diets (weeks 1 and 2, P<0.01; weeks 3, 4, 6 and 8, P<0.05; Figure 18), and 
tended to eat significantly more food by energy (weeks 1, 4, 8, and 9, P<0.01; weeks 
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3, 5, 6, and 7, P<0.05; Figure 19). As in study 1, however, the HFD animals generally 
ate significantly less than the CD animals by mass (weeks 1, 3, 5, 6, 8, and 9; P<0.01; 
Figure 20). 
6.2.2 Oral Glucose Tolerance  
There were no differences in AUC values after one month on the diet (Figure 
21). After two months on the diet, however, there was a trend towards impaired 
glucose tolerance in the HFD group (CD: 233.9 ± 15.62; HFD: 286.4 ± 21.75; 
P=0.0582, t=1.96, df = 34). Notably, in month two there was one value in the HFD 
group that was uncharacteristically low, but was not a significant outlier. As a result, 
the value was included in the analysis; without this data point, the difference 
reaches statistical significance (see discussion).  
6.2.3 Terminal Biometrics  
HFD animals had significantly heavier fat pads than CD animals (%BW: CD, 
0.4206 ± 0.02429; HFD, 0.5245 ± 0.03108; P=0.0136, t=2.63, df=28; Figure 22), 
although there were no significant differences in spleen weight, liver weight, or 
adrenal gland weight (Table 8). 
6.2.4 I-O Curves 
 There were no differences in baseline synaptic transmission, as measured by 
an IO curve (Figure 23). 
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6.2.5 Long-Term Potentiation  
In study 2 there were no differences in potentiation between HFD and CD 
animals (Figure 24). Moreover, there were no differences in the successful slice ratio 
(P=0.928, χ²=.00818, df=1; Table 9). Figure 25 provides of summary of the data for 
both amplitude (25a) and slope (25b).  
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6.3 Discussion 
As we expected, exposing the animals to the HFD at a younger age caused the 
animals to become significantly heavier than their CD counterparts over the 
duration of the feeding period. Surprisingly, however, given the increased 
susceptibility to weight gain, there were no significant differences in glucose 
tolerance after one and two months on the diet, although there were trends towards 
impaired glucose tolerance in the HFD group. Notably, at the second timepoint (i.e., 
after 8 weeks on the diet) there was one AUC value in the HFD group that was 
uncharacteristically low (greater than 2 standard deviations below the mean), 
although it did not reach significance as an outlier, and was therefore not excluded 
from the analysis; this type of low value can occur if the baseline value is either 
authentically, or erroneously high, or if the post-bolus values are authentically, or 
erroneously low. Either scenario causes the value to fall below the baseline value (at 
which the y-axis of the AUC graph is set to 0), resulting in the subtraction of a 
portion of the graph from the overall AUC. Normally, when an inaccurate reading is 
suspected, the animal is re-sampled in order to verify the value. The single 
uncharacteristically low value for AUC in the animal may have been the result of an 
experimental oversight, in that it was not immediately obvious that a second blood 
draw needed to be done to confirm the blood glucose reading. Given that the value is 
indeed much lower than even normal control values for AUC, this was likely the 
case. If one excludes this data point, the data reaches significance for month 2 
(P=0.0133), and it is therefore not unreasonable to posit that the HFD animals were 
impaired in their glucose tolerance after 2 months on the diet.  
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There were, however, no significant differences in glucose tolerance after one 
month on the diet, which is in contrast to study one, where differences were seen at 
this timepoint. The results seem to suggest that the younger animals were in fact 
less vulnerable to the effects of the diet on glucose metabolism, which is contrary to 
what is suggested in the literature (Boitard et al, 2012), and may be due to a 
compensatory effect that is more robust in younger animals. The HFD group did, 
however, have significantly heavier fat pads at the time of sacrifice (i.e., after 10 
weeks on the diet), which suggests that the shortened feeding period was indeed 
sufficient to increase adiposity when the animals were exposed to the diet during 
development. Unfortunately, we cannot say whether a similar increase in adiposity 
would have been seen in the older animals from study 1 after only 10 weeks on the 
diet, given that fat pad excision is a terminal procedure and therefore can only be 
done at the time of sacrifice. The literature would suggest, however, that insulin 
resistance is, in part, due to inflammation from excessive adipose tissue (Miller and 
Spencer, 2014), and given that the dams in study 1 were impaired in their glucose 
tolerance at both 8 and 12 weeks on the diet, it is not unreasonable to suggest that 
their fat stores were elevated with respect to CD at 10 weeks. Overall, with the 
exception of significant increases in body weight in the animals in study 2, beginning 
feeding at a younger age did not result in exaggerated metabolic effects of the HFD 
relative to study 1.  
We also saw no differences in hippocampal LTP between HFD and CD 
animals in study 2, and the slice ratio did not seem to suggest a difference between 
the groups that might have been missed as a result of our LTP threshold (54.5% and 
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56.7% success in potentiation, respectively). A possible explanation for this is 
insufficient length of exposure to the diet. Indeed, insofar as peripheral glucose 
intolerance is caused by inflammatory processes (Miller and Spencer, 2014), the 
lack of a significant impairment in metabolic control after one month on the diet 
suggests that there may not have been sufficient inflammation present to provoke 
these changes. Although the impairments in glucoregulation were apparent after 2 
months, terminal measures taken after only 10 weeks of diet exposure may not have 
allowed sufficient time for these changes to result in impairments in hippocampal 
function. Consistent with this possibility, preliminary findings from another student 
in our lab showed no diet-induced differences in protein levels of hippocampal IL-
1β, IL-6, IL-1ra, IL-10, suggesting no differences in either inflammatory, or anti-
inflammatory cytokines. In effect, all other studies showing HFD diet-induced 
impairments in LTP had considerably longer feeding periods (Erion et al, 2014; Farr 
et al, 2008; Hwang et al, 2010; Lennox et al, 2014; Porter et al, 2010; Stranahan et al, 
2008), the shortest of which was 5 months (Lennox et al, 2014). The shorter feeding 
here may therefore not have allowed sufficient time for inflammation to affect 
hippocampal function. Our biochemical data did show a decrease in hippocampal 
GFAP, a marker of astrocytic activation, in the HFD animals, which may be the 
beginning of a compensatory change in response to inflammation in the periphery 
or in other parts of the brain that was not yet sufficient to evoke inflammatory 
changes in the hippocampus. Moreover, a trend towards a decrease in total Akt was 
also seen, with no difference in phospho-Akt. Akt is part of a number of important 
signalling pathways, including insulin, leptin, and BDNF, all of which have been 
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shown to play a role in synaptic plasticity (Brunet, 2001; McNay and Recknagel, 
2011; Morrsion, 2009). These differences may therefore be indicative of preliminary 
changes in the Akt pathway, which, over time, could manifest in impaired synaptic 
plasticity, learning, and memory. Another possibility is that the HFD-induced 
changes must occur concomitantly with other changes that occur as a result of 
aging, that were not yet present in our younger animals.  
Another student in our lab conducted behavioral experiments to examine 
whether the diet had any effects on hippocampal-dependent spatial memory, as 
measured by the MWM. In accordance with the rest of our findings, there were no 
diet-induced differences in either acquisition, or retention of the task. Given that 
deficits in spatial learning performance in the MWM are often accompanied by 
impairments in LTP (Malenka and Nicoll, 1999), these results are consistent with a 
lack of diet-induced impairments in LTP in these animals. Overall, it would seem 
that shifting the feeding period to cover adolescence did not have the expected 
exaggerated effects on physiology in these animals, perhaps both because of age-
related compensatory effects, as well as insufficient timing of diet exposure.  
One important possibility, however, is that there may have been more subtle 
deficits in our animals that we may have missed with our battery of tests. Indeed, 
Boitard et al (2014) ran a similar study with 3 week-old male Wistar rats, using the 
same HFD that we used here. After 8 weeks on the diet, Boitard et al (2014) showed 
no differences in acquisition of a MWM, or on a short-term probe test (consistent 
with our results). When they performed a second probe test 4 days after the final 
44 
 
training day however (i.e., a long-term probe), the CD animals still showed a 
preference for the target quadrant, whereas the HFD animals did not, suggesting 
impaired long-term memory, or memory consolidation, in the HFD animals (Boitard 
et al, 2014). The HFD animals were also impaired on a reversal task, suggesting 
impaired mental flexibility (Boitard et al, 2014). These results suggest that, because 
we did not conduct a long-term probe or reversal task, we may have missed more 
subtle deficits in hippocampal function that may have been present in our animals. 
In line with this, recent evidence suggests that hippocampal long-term depression 
(LTD), an activity-dependent decrease in synaptic strength, is more important than 
LTP for both consolidation of spatial memory (Ge et al, 2010) and performance of 
the reversal task (Dong et al, 2013), both of which were shown to be impaired by 
Boitard et al (2014). The possibility exists, then, that measuring hippocampal LTD 
may have yielded diet-induced differences in our study. Indeed, hippocampal LTD 
has previously been shown to be impaired in the context of HFD-feeding (Hwang et 
al, 2010).  
7.0 Limitations and Future Directions 
Overall, considering the data from both studies, drawing any firm conclusions 
regarding the effects of HFD on female animals and their offspring is difficult. 
Although we did see impairments in LTP in the maternal generation in study 1, the 
same effects were neither present in the offspring, nor in the maternal generation in 
study 2. Moreover, the offspring in study 1 did not show metabolic alterations as a 
result of maternal HFD exposure, which is contrary to what is suggested in the 
literature (Li et al, 2011). The HFD offspring were, however, trending towards 
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increased body weight, suggesting that our limited sample size may not have 
allowed for the detection of significant metabolic differences. Future studies should 
therefore seek to maximize the number of successful litters in order to have 
sufficient power to detect an effect. As well, all studies investigating the effects of 
HFD on hippocampal function should attempt to incorporate behavioral tasks into 
the study design in order to assess the biological relevance of any 
electrophysiological and/or biochemical data. 
The lack of significant findings for LTP in the maternal generation of study 2 
was also unexpected, given the literature suggesting the increased vulnerability of 
younger animals to the effects of HFD (Boitard et al, 2012), as well as our data from 
study 1. Future studies should investigate the relative importance of age, diet 
duration, and diet composition on hippocampal function. As well, species, strain, and 
sex differences may add to the variability in findings between studies, and so the 
effects of these variables should be controlled for. Moreover, attention should be 
paid to the subtleties of behavioral and electrophysiological tasks, and as wide an 
array of measures should be incorporated as possible, in order to fully characterize 
the extent of cognitive deficits that may be present in these animals.  
Ultimately, it would seem that HFD feeding has the potential to disrupt brain 
function, but that this effect is dependent on a number of factors, including animal 
age, sex, duration of exposure to the diet, as well as the nature of the assessment 
being used. Given the current obesity surge, it is of paramount importance that the 
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contribution of each of these factors, the precise nature of the impairments, and the 
mechanisms underlying them be elucidated. 
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8.0 Tables and Figures 
 
 
 
 
 
 
 
 
 
  
 
Figure 1 - Image of slice on MED 64-point probe: 8 x 8 
microelectrode array surrounded by four reference electrodes. The 
electrodes are placed so as to encompass the dendritic field of area 
CA1. 
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Figure 3 – Schematic of proposed mechanistic pathway of 
impairment of hippocampal synaptic plasticity. 
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Figure 4 - Body weights at baseline, and at the end of each 
month on the diet. Data are mean +/- SEM. N=20 for both 
groups. 
Figure 5 - Food consumption as measured in grams of food 
consumed per cage of 3 rats over the duration of the feeding 
protocol. Data are mean +/- SEM. *P<0.05. **P<0.01. N=10 for 
both groups.  
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Figure 6 - Food consumption as measured in kilocalories of 
food consumed per cage of 3 rats over the duration of the 
feeding protocol. Data are mean +/- SEM. *P<0.05. N=10 for 
both groups. 
Figure 7 - Oral glucose tolerance tests were performed on all 
animals at 1, 2, 3, and 4 months on the respective diets. Data 
are mean +/- SEM. *P<0.05, **P < 0.01. N=20. 
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 Figure 8 – Retroperitoneal fat pad mass, shown as a 
percentage of body weight (% BW). Data are mean +/- SEM. 
**P ≤ 0.01. N=20. 
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(n=24, N=14) 
(n=30, N=13) 
 Figure 9 – Input-output curves. Response amplitude for 
stimulations of increasing intensity (at intervals of 5 μA). 
Shown as a percentage of initial response. n=24-30 slices from 
N=13-14 animals. 
 
 
(n=16, N=10) 
(n=24, N=13) 
 Figure 10 – fEPSP amplitude, shown as a percentage of baseline. Comparisons were 
performed for the last five minutes of post-HFS recording denoted by boxed area. 
Data are mean +/- SEM. **P ≤ 0.01. Arrow denotes high-frequency stimulation. 
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 Figure 11 – A) fEPSP amplitude, shown as a percentage of baseline. B) fEPSP Slope, 
shown as a percentage of baseline. Data are mean +/- SEM. *P<0.05, **P < 0.01.  
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 Figure 12 – Representative traces pre- and post- HFS overlaid on one another for 
both the CD and HFD groups. The bottom trace in each image is the trace post-HFS.  
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Figure 13 – A) male and B) Female offspring body weights. Data are mean +/- 
SEM. *P < 0.05, **P < 0.01. N=4 for both CD and HFD.  
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Figure 14- Oral glucose tolerance tests were performed on A) 
male and B) female offspring at PND 28 (adolescence) and 
PND 56 (young adulthood). Data are mean +/- SEM. N=4 for 
both groups.  
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 Figure 15 – Input-output curves in A) male and B) female offspring born to HFD, or CD 
mothers. Response amplitude for stimulations of increasing intensity (at intervals of 5 μA). 
Shown as a percentage of initial response. Data are mean +/- SEM. 
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Figure 16 – fEPSP amplitude, shown as a percentage of baseline. Comparisons were 
performed for the last five minutes of post-HFS recording. Data are mean +/- SEM. 
Arrow denotes high-frequency stimulation. 
 
60 
 
C D H F D  
0
5 0
1 0 0
1 5 0
2 0 0
L o n g -T e rm  P o te n t ia t io n
(fE P S P  A m p litu d e )
%
 B
a
s
e
li
n
e
 
 
C D H F D  
0
5 0
1 0 0
1 5 0
2 0 0
L o n g -T e rm  P o te n t ia t io n
(fE P S P  S lo p e )
%
 B
a
s
e
li
n
e
 
 
  Figure 17 – fEPSP A) amplitude and B) slope, shown as a percentage of baseline for 
male offspring. Comparisons were performed for the last five minutes of post-HFS 
recording. Data are mean +/- SEM.  
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Figure 18 - Body weights at baseline, and over the course of 10 
weeks on the diets. *P<0.05, **P<0.01. Data are mean +/- SEM. 
N=30 for both CD and HFD groups.   
Figure 19 - Food consumption as measured by kilocalories of 
food consumed per cage of 3 rats over the duration of the 
feeding protocol. Data are mean +/- SEM. *P<0.05, **P<0.01. 
N=10 for both groups.  
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Figure 20 - Food consumption as measured by grams of food 
consumed per cage of 3 rats over the duration of the feeding 
protocol. Data are mean +/- SEM. **P<0.01. N=10 for both 
groups. 
Figure 21 - Oral glucose tolerance tests were performed on the 
animals after 1 and 2 months on their respective diets. Data 
are mean +/- SEM. N=18 for both groups. 
** 
** 
** ** 
** ** 
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 Figure 22 – Retroperitoneal fat pad mass, shown as a percentage 
of body weight (%BW). Data are mean +/- SEM. *P ≤ 0.05. N=15 
for both groups.  
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 Figure 23 – Input-output curves in female animals. Response amplitude for stimulations of 
increasing intensity (at intervals of 2 μA). Shown as a percentage of initial response. Data 
are mean +/- SEM. 
 
(n=33, N=14) 
(n=30, N=13) 
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 Figure 24 – fEPSP amplitude, shown as a percentage of baseline. Comparisons were 
performed for the last five minutes of post-HFS recording. Data are mean +/- SEM. 
Arrow denotes high-frequency stimulation. 
 
 
(n=11, N=17) 
(n=10, N=18) 
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 Figure 25 – fEPSP A) amplitude and B) slope, shown as a percentage of baseline. 
Comparisons were performed for the last five minutes of post-HFS recording. Data 
are mean +/- SEM.  
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CD (g) HFD (g) P-value t-value df 
Baseline 194.9 ± 3.06 199.2 ± 3.65 0.3692 0.9087 38 
Month 1 240.0 ± 3.88 249.2 ± 4.47 0.1291 1.551 38 
Month 2 263.4 ± 3.49 272.2 ± 4.80 0.1439 1.492 38 
Month 3 276.2 ± 3.74 284.8 ± 4.91 0.1709 1.396 38 
Month 4 285.2 ± 4.03 295.3 ± 5.65 0.1531 1.458 38 
            
            
            
            
 
 
 
 
 
 
 
 
 
 
 
            
   
Table 1 – Body weight was monitored for all animals throughout the feeding 
period, and is shown at baseline, 1, 2, 3, and 4 months on the respective diets. 
Data are mean +/- SEM. N=20 for both CD and HFD groups. 
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CD HFD P-value t-value df 
FBG 
(mmol/L) 
6.4 ± 0.27 6.4 ± 0.19 0.8578 0.01804 38 
Spleen 
(%BW) 
0.210 ± 0.00438 0.219 ± 0.00385 0.1386 1.517 34 
Liver Weight 
(%BW) 
2.30 ± 0.036 2.23 ± 0.047 0.2649 1.132 38 
Liver Volume 
(mL/g) 
0.0214 ± 0.000463 0.0210 ± 0.000403 0.4750 0.7215 38 
Adrenal Glands 
(%BW) 
0.0220 ± 0.000610 0.0233 ± 0.000790 0.1721 1.392 38 
Retro-Peritoneal 
Fat Pads (%BW)** 
0.478 ± 0.0222 0.627 ± 0.0375 0.0015 3.433 38 
Table 2 – Summary table of terminal biometric measures. Data are mean +/- 
SEM. N=20 for all measures except for spleen weights, for which N=18. 
**P<0.01. 
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 CD HFD 
Total Slices With a Stable Baseline 30 24 
Total Slices Displaying LTP Above Threshold 24 16 
Percent Potentiated  
((LTP Slices/Stable Slices)*100) 
80% 66.67% 
            
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 – Ratio of slices displaying potentiation to slices exhibiting normal 
baseline synaptic transmission in the maternal generation. 
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Male Offspring CD HFD P-value t-value df 
FBG (mmol/L) 5.8 ± 0.56 6.0 ± 0.48 0.7776 0.2895 11 
Spleen (%BW) 0.231 ± 0.0102 0.223 ± 0.00682 0.5141 0.6742 11 
Liver Weight (%BW) 3.12 ± 0.137 3.10 ± 0.060 0.9326 0.08659 11 
Liver Volume 
(mL/g) 
0.0276 ± 0.00223 0.0255 ± 0.00212 0.5303 0.6500 10 
Adrenal Glands 
(%BW) 
0.0161 ± 0.000697 0.0155 ± 0.00125 0.6814 0.4216 11 
Retroperitoneal Fat 
pads (%BW) 
0.315 ± 0.0351 0.437 ± 0.0608 0.0992 1.801 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 – Summary of terminal biometrics for male offspring. Data are mean +/- 
SEM. CD: N=7 and HFD: N=6. 
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Female Offspring CD HFD P-value t-value df 
FBG (mmol/L) 6.3 ± 0.54 6.1 ± 0.57 0.7861 0.2781 11 
Spleen (%BW) 0.260 ± 0.00730 0.259 ± 0.0160 0.9436 0.07243 11 
Liver weight (%BW) 2.91 ± 0.108 2.86 ± 0.0837 0.6968 0.4011 10 
Liver volume (mL/g) 0.0290 ± 0.00102 0.0282 ± 0.000909 0.5858 0.5678 8 
Adrenals Glands 
(%BW) 
0.0271 ± 0.000968 0.0285 ± 0.00173 0.4742 0.7410 11 
Retroperitoneal Fat 
pads (%BW) 
0.314 ± 0.0397 0.379 ± 0.0281 0.2201 0.2201 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 – Summary of terminal biometrics for female offspring. Data are mean 
+/- SEM. CD: N=7 and HFD: N=6. 
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Male Offspring CD HFD 
Total Slices With a Stable Baseline 13 9 
Total Slices Displaying LTP Above 
Threshold 
8 5 
Percent  61.5% 55.6% 
Final Sample Size 5 2 
            
            
             
            
Female Offspring CD HFD 
Total Slices With a Stable Baseline 8 7 
Total Slices Displaying LTP Above 
Threshold 
5 1 
Percent  62.5% 14.3% 
Final Sample Size 3 1 
   
 
Table 6 – Ratio of slices displaying potentiation to slices 
exhibiting normal baseline synaptic transmission in male 
animals. 
Table 7 – Ratio of slices displaying potentiation to slices 
exhibiting normal baseline synaptic transmission in female 
animals. 
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CD HFD P-value t-value df 
Spleen (%BW) 0.255 ± 0.00932 0.240 ± 0.00381 0.1306 1.558 28 
Liver Weight 
(%BW) 
3.00 ± 0.071 3.01 ± 0.0364 0.8948 0.1335 28 
Adrenal Glands 
(%BW) 
0.0240 ± 0.000425 0.0243 ± 0.000570 0.7157 0.3679 28 
Retro-
Peritoneal Fat 
Pads (%BW)* 
0.421 ± 0.0243 0.525 ± 0.0311 0.0136 2.633 28 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8 – Summary table of terminal biometric measures. Data are mean +/- 
SEM. N=15. *P<0.05. 
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 CD HFD 
Total Slices With a Stable Baseline 33 30 
Total Slices Displaying LTP Above 
Threshold 
18 17 
Percent  54.5% 56.7% 
 
 
  
Table 9 – Ratio of slices displaying potentiation to slices 
exhibiting normal baseline synaptic transmission.  
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Appendix – Composition of Diets Used in Studies 1 and 2 
 HFD, Studies 1 and 2 CD, Study 1 CD, Study 2 
Ingredient mg kcal mg kcal Mg kcal 
Casein, 30 Mesh 200 800 0 0 0 0 
Casein, 80 Mesh 0  0 200 800 200 800 
L-Cystine 3 12 3 12 3 12 
Corn Starch 72.8 291 315 1260 550 2200 
Maltodextrin 10 100 400 35 140 150 600 
Sucrose 172.8 691 350 1400 0 0 
Cellulose, BW200 50 0 50 0 50 0 
Soybean Oil 25 225 25 225 25 225 
Lard 177.5 1598 20 180 20 180 
Mineral Mix S10026 10 0 10 0 10 0 
DiCalcium Phosphate 13 0 13 0 13 0 
Calcium Carbonate 5.5 0 5.5 0 5.5 0 
Potassium Citrate, 1H2O 16.5 0 16.5 0 16.5 0 
Vitamin Mix V10001 10 40 10 40 10 40 
Choline Bitartrate 2 0 2 0 2 0 
FD&C Red Dye #40 0.05 0 0 0 0.025 0 
FD&C Yellow Dye #5 0 0 0.05 0 0 0 
FD&C Blue Dye #1 0 0 0 0 0.025 0 
 
 
   
